(GBV-C) is a single-stranded RNA virus that is the closest known relative of hepatitis C virus (HCV). GBV-C has not been associated with any human disease to date. However, several studies have reported a beneficial effect of GBV-C viremia on HIV disease progression - reduced HIV RNA levels, increased CD4 cell counts, and slower disease progression - predominantly in cohorts with a high proportion of men. However, the prevalence of GBV-C differs significantly between men and women, and no large prospective studies have examined the effects of GBV-C co-infection on HIV disease progression in women. In a preliminary study, we found that GBV-C genotype 2 was associated with higher CD4 cell counts compared to genotype 1, and that GBV-C genotype 2 was more sensitive to clearance after interferon treatment than GBV-C genotype 1. Therefore, we propose to evaluate the presence of GBV-C co-infection and the role of GBV-C genotype in modulating HIV disease progression in a well-characterized cohort of women with HIV/AIDS to enhance our knowledge of GBV-C/HIV interactions. This work is significant and innovative because no large prospective studies of the role of GBV-C co-infection in modulating HIV disease have been reported in HIV positive women and because its addresses a potentially beneficial interaction between GBV-C and HIV that could be exploited in the future to develop novel therapeutic strategies.
To date, GB virus type C (GBV-C) has not been associated with any human disease, although several studies have reported a beneficial effect of GBV-C infection on HIV disease progression. The prevalence of GBV-C may differ by gender;however, the adventitious role of GBV-C co-infection on HIV disease, as well as the potential modulatory effects of GBV-C genotype, has not yet been evaluated in a longitudinal manner in women. Such studies could ultimately lead to novel therapeutic strategies to treat HIV disease, particularly among difficult-to-treat populations and/or individuals with limited access to antiretroviral therapy.
| Blackard, Jason T; Ma, Gang; Welge, Jeffrey A et al. (2017) Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV. J Med Virol 89:1904-1911 |
| Blackard, Jason T; Ma, Gang; Polen, Clarissa et al. (2016) Recombination among GB virus C (GBV-C) isolates in the United States. J Gen Virol 97:1537-44 |
| Schwarze-Zander, Carolynne; Blackard, Jason T; Rockstroh, Juergen K (2012) Role of GB virus C in modulating HIV disease. Expert Rev Anti Infect Ther 10:563-72 |
| Neibecker, Markus; Schwarze-Zander, Carolynne; Rockstroh, Jürgen K et al. (2011) Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany. J Med Virol 83:685-94 |
| Blackard, Jason T; Welge, Jeffrey A; Taylor, Lynn E et al. (2011) HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis 52:674-80 |
| Schwarze-Zander, Carolynne; Neibecker, Markus; Othman, Sabrina et al. (2010) GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antivir Ther 15:745-52 |
